Aprepitant is a novel, selective activator of the K2P channel TRAAK
David McCoull(LifeArc), Paul D. Wright(LifeArc), Alistair Mathie(University of Westminster), T. Avkiran(LifeArc), Egle Vaitone(LifeArc), Yvonne Walsh(Medway School of Pharmacy), Emma L. Veale(Medway School of Pharmacy), L Byrom(LifeArc), Jonathan M. Large(LifeArc), Jeffrey C. Jerman(GlaxoSmithKline (United Kingdom)), Finbar Gaffey(LifeArc)
Cited by 8
Related Papers
Guide to Receptors and Channels (GRAC), 5th edition
|British Journal of Pharmacology|2011|1.9k
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein‐coupled receptors
|British Journal of Pharmacology|2019|712
Guide to Receptors and Channels (GRAC), 3rd edition
|British Journal of Pharmacology|2008|508
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes
|British Journal of Pharmacology|2019|505
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488